AJOONI3.49

Ajooni Biotech Limited

· Unclassified
₹ CrorePeersTOUCHWOODRKECRAJMETBANKAAAKASHGANGAFORGEGLOBEAGROPHOSMcap ₹60.1 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Inventory Days (DIO)80.2990.1297.2797.27
Receivable Days (DSO)59.0451.6135.6935.69
Payable Days (DPO)8.2813.1321.9818.39
Cash Conversion Cycle (days)131.05128.60110.98114.57
Working Capital Turnover2.732.013.874.55
Asset Turnover1.691.211.521.52
Cash Conversion (CFO/Net Income)-1.83-5.26-1.33-1.33
CFO/EBITDA-1.77-4.81-0.92-0.92
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.